Automated Monocyte Activation Testing Technology for Microbial  Detection

PyroDex’s full commitment to microbial detection helps you save time and money.

Our service focuses entirely on testing injectable and implantable therapeutic products for microbial contamination, using an automated MAT technology that’s:

  • Fast

  • Comprehensive

  • Reliable

  • Quantifiable



Djik Maouyo, Ph.D.

Djikolngar Maouyo, Ph.D., is the founder and managing director of PyroDex LLC. Dr. Maouyo has more than 25 years of experience in industrial biotechnology and academic biomedical research, and has focused specifically on microbial detection for the past nine years. He has worked intensively in the development of microbial detection kits and researched budding technologies in microbial detection throughout the United States and Europe for the past five years.

Prior to founding PyroDex, he held faculty research positions at the Johns Hopkins University School of Medicine and the University of Maryland Baltimore, and most recently was senior scientist at a multinational biotech firm. He has a Ph.D. in animal physiology from the University of Sherbrooke in Canada and has held postdoctoral fellowships in microbiology and molecular biology, at the University of Montreal and the Johns Hopkins School of Medicine respectively.

Industrial Expertise


We have experience in microbial contamination detection:

  • Good manufacturing practices

  • Good laboratory practices

  • International Standard Organization

  • US & European Pharmacopeia Testing Guidelines


Watch a video about Pyrodex Testing by the Lifebridge Bioincubator: